Real-world diabetic macular edema care lags trials as fewer VEGF injections and step therapy limit outcomes.
Rahul Khurana, MD
Advertisement
Rahul Khurana, MD, is partner and president/CEO of Northern California Retina Vitreous Associates and volunteer clinical associate professor in ophthalmology at the University of California, San Francisco.
Articles by Rahul Khurana, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Emerging Data Suggest Survodutide Targets Liver Fat More Rapidly Than Weight Loss: Lee Kaplan, MD, PhD
2
Survodutide Normalizes Liver Fat in 61% of Patients With MASLD in Phase 3 Trial: Lee Kaplan, MD, PhD
3
Bridging Science and Reality in Diabetes Care
4
Nutrition in Pregnancy May Shape Metabolic Health After Delivery
5